EXHI
Price
$0.60
Change
+$0.09 (+17.65%)
Updated
Jun 27 closing price
Capitalization
N/A
SHTDF
Price
$2.16
Change
-$0.02 (-0.92%)
Updated
Jun 30 closing price
Capitalization
9.79B
Interact to see
Advertisement

EXHI vs SHTDF

Header iconEXHI vs SHTDF Comparison
Open Charts EXHI vs SHTDFBanner chart's image
Exlites Holdings International
Price$0.60
Change+$0.09 (+17.65%)
Volume$1.61K
CapitalizationN/A
Sinopharm Group
Price$2.16
Change-$0.02 (-0.92%)
Volume$200
Capitalization9.79B
EXHI vs SHTDF Comparison Chart in %
Loading...
EXHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXHI vs. SHTDF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXHI is a Hold and SHTDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (EXHI: $0.60 vs. SHTDF: $2.16)
Brand notoriety: EXHI and SHTDF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: EXHI: 311% vs. SHTDF: 36%
Market capitalization -- EXHI: $0 vs. SHTDF: $9.79B
EXHI [@Medical Distributors] is valued at $0. SHTDF’s [@Medical Distributors] market capitalization is $9.79B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXHI’s FA Score shows that 0 FA rating(s) are green whileSHTDF’s FA Score has 1 green FA rating(s).

  • EXHI’s FA Score: 0 green, 5 red.
  • SHTDF’s FA Score: 1 green, 4 red.
According to our system of comparison, EXHI is a better buy in the long-term than SHTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXHI’s TA Score shows that 5 TA indicator(s) are bullish while SHTDF’s TA Score has 1 bullish TA indicator(s).

  • EXHI’s TA Score: 5 bullish, 2 bearish.
  • SHTDF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, EXHI is a better buy in the short-term than SHTDF.

Price Growth

EXHI (@Medical Distributors) experienced а +17.23% price change this week, while SHTDF (@Medical Distributors) price change was -1.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.

Industries' Descriptions

@Medical Distributors (+2.01% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXHI YTD gains are higher at: 61.679 vs. SHTDF (-13.253).
EXHISHTDFEXHI / SHTDF
CapitalizationN/A9.79B-
EBITDAN/A24.7B-
Gain YTD61.679-13.253-465%
P/E RatioN/A8.00-
RevenueN/A521B-
Total CashN/A43.5B-
Total DebtN/A68.4B-
FUNDAMENTALS RATINGS
EXHI vs SHTDF: Fundamental Ratings
EXHI
SHTDF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10057
PRICE GROWTH RATING
1..100
3562
P/E GROWTH RATING
1..100
10056
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDF's Valuation (21) in the null industry is in the same range as EXHI (42). This means that SHTDF’s stock grew similarly to EXHI’s over the last 12 months.

SHTDF's Profit vs Risk Rating (100) in the null industry is in the same range as EXHI (100). This means that SHTDF’s stock grew similarly to EXHI’s over the last 12 months.

SHTDF's SMR Rating (57) in the null industry is somewhat better than the same rating for EXHI (100). This means that SHTDF’s stock grew somewhat faster than EXHI’s over the last 12 months.

EXHI's Price Growth Rating (35) in the null industry is in the same range as SHTDF (62). This means that EXHI’s stock grew similarly to SHTDF’s over the last 12 months.

SHTDF's P/E Growth Rating (56) in the null industry is somewhat better than the same rating for EXHI (100). This means that SHTDF’s stock grew somewhat faster than EXHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EXHISHTDF
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
70%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 3 days ago
69%
MACD
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
48%
Bearish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
59%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
EXHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPWR4.700.21
+4.68%
Ideal Power
CRMT62.050.69
+1.12%
America's Car-Mart
TFINP22.000.22
+1.01%
Triumph Financial
RLJ7.570.03
+0.40%
RLJ Lodging Trust
MKSI104.56-0.06
-0.06%
MKS Inc

EXHI and

Correlation & Price change

A.I.dvisor tells us that EXHI and SHTDY have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXHI and SHTDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXHI
1D Price
Change %
EXHI100%
N/A
SHTDY - EXHI
5%
Poorly correlated
+0.35%
SHTDF - EXHI
1%
Poorly correlated
N/A

SHTDF and

Correlation & Price change

A.I.dvisor tells us that SHTDF and SHTDY have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDF and SHTDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDF
1D Price
Change %
SHTDF100%
N/A
SHTDY - SHTDF
19%
Poorly correlated
+0.35%
COR - SHTDF
17%
Poorly correlated
+1.74%
SHPMY - SHTDF
12%
Poorly correlated
N/A
CAH - SHTDF
12%
Poorly correlated
N/A
AHG - SHTDF
10%
Poorly correlated
+9.82%
More